Hypercortisolism
18
7
7
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
5.6%
1 terminated out of 18 trials
85.7%
-0.8% vs benchmark
11%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (18)
Effects of Metyrapone in Patients With Hypercortisolism
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)
Serum and Salivary Cortisol Assessment in Patients With Adrenal Incidentalomas and Healthy Controls
Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism
Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas
A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations
Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism
Hypercortisolism and Epicardial Adipose Tissue
Cortisol Secretion, Sensitivity and Activity and Hypertension
Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients
Liquorice and Salivary Cortisol
Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome